Aug 2026· Current Addiction Report· Vol 13· 0 citations· 77 references
TL;DR
Current evidence supports individualized use of MOUD while accounting for comorbidities, polypharmacy, and age-related physiologic changes, and future research should prioritize geriatric-specific screening tools, diagnostic frameworks, treatment protocols, and clinical outcomes.
Abstract
To summarize current evidence regarding the epidemiology, risk factors, diagnosis, and treatment of opioid use disorder (OUD) in older adults, with emphasis on age-specific challenges related to screening, clinical presentation, pharmacologic management, and emerging treatment approaches. OUD among older adults is increasing despite declining opioid prescribing rates, with rising rates of opioid-related hospitalization and overdose mortality. Diagnosis remains challenging because age-related physiologic changes, polypharmacy, and cognitive impairment may obscure traditional manifestations of OUD. Existing screening instruments and diagnostic criteria have important limitations in elderly populations. Medications for opioid use disorder (MOUD) remain the cornerstone of treatment, with buprenorphine being favored for its safety profile and flexible formulations. Older adults represent a clinically distinct and understudied population with OUD. Current evidence supports individualized use of MOUD while accounting for comorbidities, polypharmacy, and age-related physiologic changes. Future research should prioritize geriatric-specific screening tools, diagnostic frameworks, treatment protocols, and clinical outcomes.
This review examines epidemiology, clinical features, diagnostic challenges, and treatment strategies for older adults with bipolar disorder, requiring a balance between evidence-based pharmacological treatments, psychosocial support, and careful attention to comorbidities and functional status.
Pain management in older adults presents unique challenges owing to age-related physiological changes, comorbidities, polypharmacy, and heightened vulnerability to opioid-related adverse effects. This consensus review synthesizes current evidence and expert opinion on the safe and effective use of opioids in older adul...
Hugo Ribeiro, J. Neves, Paulo Roberto et al.· Drugs & Aging· 0 citations
Current evidence indicates that long-term benzodiazepine use in geriatric patients is associated with significant and potentially preventable harms, and structured deprescribing strategies and increased adherence to clinical guidelines are essential to improving patient safety in older populations.
I. Rusin, A. Wrzesińska, Mateusz Korowacki et al.· International Journal of Inn...· 0 citations
Clozapine remains the gold-standard treatment for refractory schizophrenia, yet its use in older adults is often limited by concerns regarding tolerability, age-related pharmacokinetic changes, and the burden of medical comorbidities. This narrative review synthesises current evidence on clozapine use in older populati...
Kate Mulholland, Brian O'Donoghue, D. Siskind et al.· Therapeutic Advances in Psyc...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.